Piramal Pharma Ltd | A block deal is likely to be launched in with the seller likely to sell around 6% of the company's total equity.
The seller is seeking to raise approximately ₹1,750 crore through the transaction.
The deal may be offered at a minor discount to the current market price (CMP).
Piramal Pharma Ltd | A block deal is likely to be launched in with the seller likely to sell around 6% of the company's total equity. The seller is seeking to raise approximately ₹1,750 crore through the transaction. The deal may be offered at a minor discount to the current market price (CMP).
